On June 10, 2016, Alexey Vinogradov resigned from Argos Therapeutics, Inc.'s Board of Directors. Also on June 10, 2016, following the resignation of Dr. Vinogradov from the Board, the Board elected Igor Krol, effective immediately, as a director of the company, to fill the vacancy resulting from the resignation of Dr. Vinogradov, and to serve as a Class I director of the company, with a term expiring at the company's 2018 Annual Meeting of Stockholders.